AU7256987A - Method of affinity purification employing monoclonal antibodies - Google Patents

Method of affinity purification employing monoclonal antibodies

Info

Publication number
AU7256987A
AU7256987A AU72569/87A AU7256987A AU7256987A AU 7256987 A AU7256987 A AU 7256987A AU 72569/87 A AU72569/87 A AU 72569/87A AU 7256987 A AU7256987 A AU 7256987A AU 7256987 A AU7256987 A AU 7256987A
Authority
AU
Australia
Prior art keywords
monoclonal antibodies
affinity purification
employing monoclonal
purification employing
affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU72569/87A
Other versions
AU622099B2 (en
Inventor
Richard M. Bartholomew
Daniel E. Beidler
Gary S. David
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of AU7256987A publication Critical patent/AU7256987A/en
Application granted granted Critical
Publication of AU622099B2 publication Critical patent/AU622099B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU72569/87A 1982-04-12 1987-05-06 Method of affinity purification employing monoclonal antibodies Ceased AU622099B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36778182A 1982-04-12 1982-04-12
US367781 1982-04-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU15507/83A Division AU1550783A (en) 1982-04-12 1983-04-12 Method of affinity purification employing monoclonal antibodies

Publications (2)

Publication Number Publication Date
AU7256987A true AU7256987A (en) 1987-09-03
AU622099B2 AU622099B2 (en) 1992-04-02

Family

ID=23448565

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72569/87A Ceased AU622099B2 (en) 1982-04-12 1987-05-06 Method of affinity purification employing monoclonal antibodies

Country Status (11)

Country Link
EP (1) EP0105359A4 (en)
AT (1) AT393386B (en)
AU (1) AU622099B2 (en)
CA (1) CA1209907A (en)
CH (1) CH672028A5 (en)
DK (1) DK192191A (en)
ES (3) ES8404858A1 (en)
FI (1) FI88403C (en)
GB (1) GB2128630B (en)
IT (1) IT1219779B (en)
WO (1) WO1983003678A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU600311B2 (en) * 1987-10-05 1990-08-09 Becton Dickinson & Company Method for purification of antibodies

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
GB8331071D0 (en) * 1983-11-22 1983-12-29 Karayiannis P Assay for dna/rna
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4789631A (en) * 1984-02-17 1988-12-06 Synbiotics Corporation Immunoassay for anti-dirofilaria immitis antibody
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
US4818687A (en) * 1985-02-28 1989-04-04 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
US4859611A (en) * 1985-02-28 1989-08-22 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
IL75828A (en) * 1985-07-17 1991-06-10 Univ Ramot Immobilization by biologically active proteins
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
US5175255A (en) * 1987-03-23 1992-12-29 Amgen Inc. Methods for purification of platelet-derived growth factor
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
SE468653B (en) * 1987-03-06 1993-02-22 Perstorp Biolytica ADSORBENT FOR ISOCRATIC AFFINITY CHROMATOGRAPHY
JPS6463599A (en) * 1987-05-01 1989-03-09 Xoma Corp Purification of immunoglobulin by selective anti-idiotype bond
ATE76974T1 (en) * 1987-07-14 1992-06-15 Univ Manchester PROCEDURE FOR DIAGNOSIS OF INFECTION IN WHICH LIPOPOLYSCACCHARID ANTIGENS ARE DETERMINED.
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
JP2001515345A (en) * 1996-09-20 2001-09-18 ザ・ジェネラル・ホスピタル・コーポレイション Compositions and methods for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
TWI564021B (en) * 2008-04-11 2017-01-01 Chugai Pharmaceutical Co Ltd Repeated binding of antigen to antigen binding molecules
MX365235B (en) 2010-11-30 2019-05-28 Chugai Pharmaceutical Co Ltd Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly.
US20140093496A1 (en) 2011-02-25 2014-04-03 Chugai Seiyaku Kabushiki Kaisha Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY
US20150050269A1 (en) 2011-09-30 2015-02-19 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
US20150056182A1 (en) 2011-11-30 2015-02-26 Chugai Seiyaku Kabushiki Kaisha Drug containing carrier into cell for forming immune complex
CN113045650A (en) 2014-12-19 2021-06-29 中外制药株式会社 anti-C5 antibodies and methods of use
CA2963760A1 (en) 2014-12-19 2016-06-23 Yoshinao Ruike Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
EP3394098A4 (en) 2015-12-25 2019-11-13 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
CA3026050A1 (en) 2016-08-05 2018-02-08 Chugai Seiyaku Kabushiki Kaisha Composition for prophylaxis or treatment of il-8 related diseases
JP7191833B2 (en) 2017-01-30 2022-12-19 中外製薬株式会社 Anti-sclerostin antibodies and uses thereof
CN110724204B (en) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Method for purifying Fc fusion protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
ATE14269T1 (en) * 1981-02-26 1985-08-15 Unilever Nv METHOD AND DEVICE FOR RECOVERING IMMUNOGLOBULINES.
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU600311B2 (en) * 1987-10-05 1990-08-09 Becton Dickinson & Company Method for purification of antibodies

Also Published As

Publication number Publication date
FI88403C (en) 1993-05-10
CH672028A5 (en) 1989-10-13
AT393386B (en) 1991-10-10
IT1219779B (en) 1990-05-24
FI834530A (en) 1983-12-09
GB8332644D0 (en) 1984-01-11
IT8320550A0 (en) 1983-04-12
ES521371A0 (en) 1984-05-16
ES528001A0 (en) 1987-07-01
ES8506902A1 (en) 1985-08-01
ES8404858A1 (en) 1984-05-16
WO1983003678A1 (en) 1983-10-27
AU622099B2 (en) 1992-04-02
ATA901983A (en) 1991-03-15
FI834530A0 (en) 1983-12-09
GB2128630B (en) 1986-08-28
ES8706964A1 (en) 1987-07-01
EP0105359A1 (en) 1984-04-18
CA1209907A (en) 1986-08-19
FI88403B (en) 1993-01-29
DK192191D0 (en) 1991-11-26
GB2128630A (en) 1984-05-02
ES528000A0 (en) 1985-08-01
EP0105359A4 (en) 1984-08-20
DK192191A (en) 1991-11-26

Similar Documents

Publication Publication Date Title
AU7256987A (en) Method of affinity purification employing monoclonal antibodies
AU564383B2 (en) Monoclonal antibody immunoassay
IL73883A (en) Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
BG60017B2 (en) Method for reducing the heterogeneity of monoclonal antibodies
GB8316001D0 (en) Monoclonal antibodies
AU530649B2 (en) Method of manufacturing monoclonal antibodies and capable of manufacturing such antibodies
AU7988282A (en) Method of manufacturing monoclonal antibodies and capable of manufacturing such antibodies
GB8426467D0 (en) Monoclonal antibodies
GB8426463D0 (en) Monoclonal antibodies
GB8422650D0 (en) Monoclonal antibodies
GB8422653D0 (en) Monoclonal antibodies
GB2163178B (en) Novel monoclonal antibody
GB8426461D0 (en) Monoclonal antibodies
AU1550783A (en) Method of affinity purification employing monoclonal antibodies
GB8422651D0 (en) Monoclonal antibodies
GB8422649D0 (en) Monoclonal antibodies
GB8426468D0 (en) Monoclonal antibodies
GB8426464D0 (en) Monoclonal antibodies
GB8426470D0 (en) Monoclonal antibodies
GB8426459D0 (en) Monoclonal antibodies
GB8431171D0 (en) Monoclonal antibodies
GB8426469D0 (en) Monoclonal antibodies
GB8426465D0 (en) Monoclonal antibodies
GB8419456D0 (en) Monoclonal antibodies
GB8416845D0 (en) Monoclonal antibodies